Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;35(3):783-785.
doi: 10.1007/s40620-022-01276-2. Epub 2022 Feb 22.

Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients

Pierre Housset  1 , Sabah Kubab  2 , Agathe Pardon  3 , Nathalie Vittoz  3 , Dogan-Firat Bozman  3 , Latifa Hanafi  3 , Valérie Caudwell  3 , Anne-Laure Faucon  4   5
Affiliations

Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients

Pierre Housset et al. J Nephrol. 2022 Apr.
No abstract available

Keywords: COVID-19; Hemodialysis; Humoral response; Peritoneal dialysis; SARS-CoV-2; mRNA BNT162b2 vaccine.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Kinetics of anti-spike antibodies before and after the third vaccine dose. Figure shows the anti-spike antibody levels before, and one, three and 6 months after the third dose of the mRNA BNT162b2 vaccine in dialysis patients. Each point represents individual data. Antibody titers lower than 1 could not be plotted in the graph because of logarithm scale. Horizontal lines indicate the median with interquartile range. The Wilcoxon signed rank test was used to analyze the paired data
See this image and copyright information in PMC

References

    1. Bensouna I, Caudwell V, Kubab S, et al. SARS-CoV-2 antibody response after a third dose of the BNT162b2 vaccine in patients receiving maintenance hemodialysis or peritoneal dialysis. Am J Kidney Dis. 2021 doi: 10.1053/j.ajkd.2021.08.005. - DOI - PMC - PubMed
    1. Ducloux D, Colladant M, Chabannes M, et al. Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis. Kidney Int. 2021;100:702–704. doi: 10.1016/j.kint.2021.06.025. - DOI - PMC - PubMed
    1. Robert T, Lano G, Giot M, et al. Humoral response after SARS-COV2 vaccination in patient undergoing maintenance hemodialysis: loss of immunity, third dose and non-responders. Nephrol Dial Transplant. 2021 doi: 10.1093/ndt/gfab299. - DOI - PubMed
    1. Muench P, Jochum S, Wenderoth V, et al. Development and validation of the elecsys anti-SARS-CoV-2 immunoassay as a highly specific tool for determining past exposure to SARS-CoV-2. J Clin Microbiol. 2020;58:e01694–e1720. doi: 10.1128/JCM.01694-20. - DOI - PMC - PubMed
    1. Infantino M, Pieri M, Nuccetelli M, et al. The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays. Int Immunopharmacol. 2021;100:108095. doi: 10.1016/j.intimp.2021.108095. - DOI - PMC - PubMed

LinkOut - more resources